443 related articles for article (PubMed ID: 30593649)
1. Staging systems of hepatocellular carcinoma: A review.
Tellapuri S; Sutphin PD; Beg MS; Singal AG; Kalva SP
Indian J Gastroenterol; 2018 Nov; 37(6):481-491. PubMed ID: 30593649
[TBL] [Abstract][Full Text] [Related]
2. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.
Li JW; Goh BG; Chang PE; Tan CK
World J Gastroenterol; 2017 Jun; 23(22):4054-4063. PubMed ID: 28652658
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
Farinati F; Vitale A; Spolverato G; Pawlik TM; Huo TL; Lee YH; Frigo AC; Giacomin A; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Biasini E; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Masotto A; Trevisani F; Cillo U;
PLoS Med; 2016 Apr; 13(4):e1002006. PubMed ID: 27116206
[TBL] [Abstract][Full Text] [Related]
4. Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology.
Liu PH; Hsu CY; Lee YH; Su CW; Hsia CY; Huang YH; Chiou YY; Lin HC; Huo TI
Medicine (Baltimore); 2015 Oct; 94(41):e1772. PubMed ID: 26469917
[TBL] [Abstract][Full Text] [Related]
5. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kim KM; Sinn DH; Jung SH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Liver Int; 2016 Oct; 36(10):1490-7. PubMed ID: 26936471
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Hong Kong Liver Cancer Staging System in Europe.
Kolly P; Reeves H; Sangro B; Knöpfli M; Candinas D; Dufour JF
Liver Int; 2016 Jun; 36(6):911-7. PubMed ID: 26677809
[TBL] [Abstract][Full Text] [Related]
7. Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms.
Lee YS; Seo YS; Kim JH; Lee J; Kim HR; Yoo YJ; Kim TS; Kang SH; Suh SJ; Joo MK; Jung YK; Lee BJ; Yim HJ; Yeon JE; Kim JS; Park JJ; Um SH; Bak YT; Byun KS
Gut Liver; 2018 Jan; 12(1):94-101. PubMed ID: 28873509
[TBL] [Abstract][Full Text] [Related]
8. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
Yau T; Tang VY; Yao TJ; Fan ST; Lo CM; Poon RT
Gastroenterology; 2014 Jun; 146(7):1691-700.e3. PubMed ID: 24583061
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.
Giannini E; Risso D; Botta F; Romagnoli P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Testa R
J Intern Med; 2004 Mar; 255(3):399-408. PubMed ID: 14871465
[TBL] [Abstract][Full Text] [Related]
10. Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients.
Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Su CW; Lee FY; Lin HC; Huo TI
Eur J Cancer; 2016 Aug; 63():25-33. PubMed ID: 27259100
[TBL] [Abstract][Full Text] [Related]
11. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F
Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831
[TBL] [Abstract][Full Text] [Related]
12. BCLC-B Subclassification and the Hong Kong Liver Cancer System in Intermediate Hepatocellular Carcinoma: Identifying Candidates for Curative Therapy.
Longo L; Rodrigues de Freitas LB; Santos D; Grivicich I; Álvares-da-Silva MR
Am J Clin Oncol; 2019 May; 42(5):466-471. PubMed ID: 30913090
[TBL] [Abstract][Full Text] [Related]
13. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.
Heinrich S; Sprinzl M; Schmidtmann I; Heil E; Koch S; Czauderna C; Heinrich B; Philippe P Diggs L; Wörns MA; Kloeckner R; Galle PR; Marquardt JU; Weinmann A
United European Gastroenterol J; 2020 May; 8(4):444-452. PubMed ID: 32213028
[TBL] [Abstract][Full Text] [Related]
14. Impact of current staging systems on treatment strategy for HBV-related hepatocellular carcinoma.
Yan X; Qiu Y
Cancer Lett; 2016 Sep; 379(2):220-4. PubMed ID: 26282785
[TBL] [Abstract][Full Text] [Related]
15. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G
Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992
[TBL] [Abstract][Full Text] [Related]
17. A model to estimate survival in ambulatory patients with hepatocellular carcinoma: Can it predict the natural course of hepatocellular carcinoma?
Choi WM; Yu SJ; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Cho EJ; Lee JH; Kim YJ; Yoon JH
Dig Liver Dis; 2017 Nov; 49(11):1273-1279. PubMed ID: 28807489
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable.
Wallace MC; Knuiman M; Huang Y; Garas G; Adams LA; MacQuillan G; Preen DB; Jeffrey GP
Dig Dis Sci; 2018 Sep; 63(9):2277-2284. PubMed ID: 29808245
[TBL] [Abstract][Full Text] [Related]
19. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS
J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761
[TBL] [Abstract][Full Text] [Related]
20. Validity of the Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for hepatocellular carcinoma in Singapore.
Selby LK; Tay RX; Woon WW; Low JK; Bei W; Shelat VG; Pang TC; Junnarkar SP
J Hepatobiliary Pancreat Sci; 2017 Mar; 24(3):143-152. PubMed ID: 28012284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
